Cerecor (CERC) Reports Q2 Loss of $0.41/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. FIS
5. BROS
6. QCOM
7. DDOG
8. EW
9. ZG
10. CPAY

Go back to Cerecor (CERC) Reports Q2 Loss of $0.41/Share

Cerecor Inc. Reports Second Quarter 2016 Financial Results

August 15, 2016 9:10 AM EDT

BALTIMORE--(BUSINESS WIRE)-- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders, today announced its financial results for the second quarter ended June 30, 2016.

We are excited about both of our Phase 2 programs and are encouraged by the scientific communitys increasing interest in CERC-501, having recently received grants from both the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism and being accepted for participation in a consortium with the Pharmacotherapies... More